0001209191-19-054871.txt : 20191104
0001209191-19-054871.hdr.sgml : 20191104
20191104161123
ACCESSION NUMBER: 0001209191-19-054871
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191101
FILED AS OF DATE: 20191104
DATE AS OF CHANGE: 20191104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bhatia Sangeeta N.
CENTRAL INDEX KEY: 0001643921
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 191189905
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-01
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001643921
Bhatia Sangeeta N.
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2019-11-01
4
M
0
1291
152.74
A
6540
D
Common Stock
2019-11-01
4
S
0
1291
200.00
D
5249
D
Stock Option (Right to Buy)
152.74
2019-11-01
4
M
0
1291
0.00
D
2028-05-31
Common Stock
1291
1938
D
Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.
Fully vested.
/s/ Omar White, Attorney-in-Fact
2019-11-04